OM:BIOG BBiotechs
Colon Health Launch Might Change The Case For Investing In BioGaia (OM:BIOG B)
BioGaia launched BioGaia Colus in 2026, a clinically tested, FODMAP friendly colon health probiotic using proprietary L. reuteri BG-R59 in delayed release vegan capsules, starting in the UK with further markets to follow.
The focus on a lower GI targeted, adult probiotic backed by randomized, double blind, placebo controlled trials adds depth to BioGaia’s adult gut health portfolio and supports its research driven product strategy.
We will now examine how BioGaia's product led investment...